 |  |
Bharat Biotech signs agreement with Ocugen to commercialise Covaxin in Canada
Ocugen, Inc., a biopharmaceutical company, and Bharat Biotech, a global leader in vaccine innovation, announced that they have entered into an amendment to their co-development, supply, and commercialization agreement to expand Ocugen's exclusive territory to commercialize Covaxin to now also include Canada
Bharat Biotech Signs Agreement With Ocugen To Comm | 04/06/2021 | By Darshana | 145
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy